[{"address1": "2450 Holcombe Boulevard", "address2": "Suite X", "city": "Houston", "state": "TX", "zip": "77021", "country": "United States", "phone": "832 834 9144", "website": "https://www.salariuspharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing treatments for cancers with unmet medical need. Its lead candidate is Seclidemstat (SP-2577), a small molecular inhibitor which is in Phase I/II clinical trial for the treatment of advanced solid tumors, as well as Ewing sarcoma. The company also offers SP-3164, a small molecular protein degrader for the treatment of hematological and solid tumors. It has a strategic partnership with The University of Utah Research Foundation for the exclusive license with respect to patent rights protecting SP-2577 and related compounds and Cancer Prevention and Research Institute of Texas for product development activities. The company is headquartered in Houston, Texas.", "fullTimeEmployees": 2, "companyOfficers": [{"maxAge": 1, "name": "Mr. David J. Arthur M.B.A.", "age": 61, "title": "CEO, President & Director", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 726185, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark J. Rosenblum CPA", "age": 71, "title": "Executive VP of Finance & CFO", "yearBorn": 1953, "fiscalYear": 2024, "totalPay": 339050, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.03, "open": 1.06, "dayLow": 0.97, "dayHigh": 1.06, "regularMarketPreviousClose": 1.03, "regularMarketOpen": 1.06, "regularMarketDayLow": 0.97, "regularMarketDayHigh": 1.06, "payoutRatio": 0.0, "beta": 0.592, "forwardPE": -0.11450381, "volume": 58522, "regularMarketVolume": 58360, "averageVolume": 2248193, "averageVolume10days": 322880, "averageDailyVolume10Day": 322880, "bid": 1.03, "ask": 1.08, "bidSize": 1, "askSize": 1, "marketCap": 1662748, "fiftyTwoWeekLow": 0.906, "fiftyTwoWeekHigh": 7.2, "fiftyDayAverage": 1.85308, "twoHundredDayAverage": 2.01745, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -1441965, "profitMargins": 0.0, "floatShares": 1329194, "sharesOutstanding": 1583570, "sharesShort": 10411, "sharesShortPriorMonth": 311722, "sharesShortPreviousMonthDate": 1736899200, "dateShortInterest": 1739491200, "sharesPercentSharesOut": 0.0066000004, "heldPercentInsiders": 0.022909999, "heldPercentInstitutions": 0.05238, "shortRatio": 0.04, "shortPercentOfFloat": 0.0066000004, "impliedSharesOutstanding": 1583570, "bookValue": 2.029, "priceToBook": 0.5174963, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -4993640, "trailingEps": -5.14, "forwardEps": -9.17, "lastSplitFactor": "1:8", "lastSplitDate": 1718582400, "enterpriseToEbitda": 0.277, "52WeekChange": -0.8071104, "SandP52WeekChange": 0.121255875, "quoteType": "EQUITY", "currentPrice": 1.05, "recommendationKey": "none", "totalCash": 3284029, "totalCashPerShare": 2.279, "ebitda": -5211881, "totalDebt": 328849, "quickRatio": 3.514, "currentRatio": 4.09, "debtToEquity": 11.244, "returnOnAssets": -0.53169, "returnOnEquity": -1.10868, "freeCashflow": -3998829, "operatingCashflow": -5294048, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SLRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 1.9417458, "regularMarketPrice": 1.05, "shortName": "Salarius Pharmaceuticals, Inc.", "corporateActions": [], "postMarketTime": 1741395562, "marketState": "CLOSED", "exchange": "NCM", "messageBoardId": "finmb_330031056", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "longName": "Salarius Pharmaceuticals, Inc.", "regularMarketTime": 1741381201, "earningsTimestampStart": 1742468340, "earningsTimestampEnd": 1742817600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -5.14, "epsForward": -9.17, "fiftyDayAverageChange": -0.8030801, "fiftyDayAverageChangePercent": -0.43337584, "twoHundredDayAverageChange": -0.96745014, "twoHundredDayAverageChangePercent": -0.47954106, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1422541800000, "postMarketChangePercent": 1.79048, "postMarketPrice": 1.0688, "postMarketChange": 0.0188, "regularMarketChange": 0.01999998, "regularMarketDayRange": "0.97 - 1.06", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 2248193, "fiftyTwoWeekLowChange": 0.14399993, "fiftyTwoWeekLowChangePercent": 0.15894032, "fiftyTwoWeekRange": "0.906 - 7.2", "fiftyTwoWeekHighChange": -6.1499996, "fiftyTwoWeekHighChangePercent": -0.8541666, "fiftyTwoWeekChangePercent": -80.711044, "dividendDate": 1563753600, "displayName": "Salarius Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-03-08"}]